Citius Pharmaceuticals, Inc. Prepaid Expense, Current
Citius Pharmaceuticals, Inc. (CTXR) had Prepaid Expense, Current of $3.01 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Prepaid Expense, Current
us-gaap:PrepaidExpenseCurrent · last filed 2026-08-14
- 2026-06-30: Prepaid Expense, Current $3.01M.
- 2026-03-31: Prepaid Expense, Current $3.36M.
- 2025-12-31: Prepaid Expense, Current $3.54M.
- 2025-09-30: Prepaid Expense, Current $1.40M.
| Period end | Prepaid Expense, Current | Prepaid Expense, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.01M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $3.36M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $3.54M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $1.40M 10-Q · filed 2026-08-14 | |
| 2025-06-30 | $1.31M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $3.01M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $2.85M 10-Q · filed 2025-02-14 | |
| 2024-09-30 | $2.70M 10-K · filed 2025-12-23 | |
| 2024-06-30 | $10.09M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $9.01M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.86M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $7.89M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $7.83M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $5.84M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $5.43M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $2.85M 10-K · filed 2023-12-29 | |
| 2022-06-30 | $2.79M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $2.52M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $2.74M 10-K · filed 2022-12-22 | |
| 2021-06-30 | $1.27M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.28M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $1.28M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $122.24K 10-K · filed 2021-12-15 | |
| 2020-06-30 | $51.58K 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $53.66K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $55.75K 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $48.11K 10-K · filed 2020-12-16 | |
| 2019-06-30 | $46.62K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $46.62K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $46.62K 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $57.73K 10-K · filed 2019-12-16 | |
| 2018-06-30 | $73.13K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $64.79K 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $110.82K 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $220.25K 10-K · filed 2018-12-11 | |
| 2017-06-30 | $357.81K 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $282.14K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $443.53K 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $598.48K 10-K · filed 2017-12-13 | |
| 2016-06-30 | $394.43K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $20.54K 10-Q · filed 2016-05-20 | |
| 2015-12-31 | $60.00K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $60.00K 10-K · filed 2016-12-23 | |
| 2015-06-30 | $5.92K 10-Q · filed 2015-08-13 | |
| 2013-12-31 | $9.17K 10-KT · filed 2014-12-29 | $5.95K 10-Q · filed 2014-02-19 |
| 2013-09-30 | $0.00 10-Q · filed 2014-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |